As it turns out, many perceptions about the pharmaceutical industry are based without all of the facts.


That’s why we’re sitting down to understand the data with Ravi Mehrotra, Thought Leader and former Senior Managing Director of Biotechnology Equity Research at Evercore ISI.


What we talked about:
- Defining WBPI while taking a closer look at the industry
- The reality that winners pay for all the losers
- Risk and profitability
- HR3 legislation
- Wall Street’s position on the drug pricing debate


Check out these resources we mentioned during the podcast:
- HR 3 legislation


As we continue this new journey together, we would love to hear from you, the listener. Email [email protected] or [email protected] what’s top of mind, what story you want to hear, or what you find interesting!


To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.